Recent Updates in Upper Gl Cancers

Integrity CE

S. Mukherjee

ASCO® 2024 Summary: "Expert Panel Discussion on Upper-GI Cancers Inc…

2024 ASCO® Annual Meeting Insights Hub

N. Uboha, A. Turk, K. Spencer, M. Cecchini

Year in Review: Upper GI Cancers

Moffitt Cancer Center

R. Kim, R. Mehta

Opus One: Final Results - RFA in Axial Skeleton

Jason Levy

Overview of Esophageal & Gastric Cancer Diagnosis & Staging

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

V. Shankaran

ESMO 2024 Insights: DESTINY-Gastric03 - T-DXd Monotherapy and Combin…

2024 ESMO Annual Meeting Insights Hub

Y. Janjigian

ASCO® GI 2024 Summary: "Esophageal Squamous Cell Carcinoma Key Studi…

Insights from 2024 ASCO® GI Annual Meeting

R. Kim, R. Mehta

Prevention of Esophageal Cancer: Screening and Surveillance

Dana-Farber Cancer Institute

K. Jajoo

GI Cancer Updates: The Role of Surgery After Neoadjuvant Systemic Th…

Yale Cancer Center

C. Balch

Gastroesophageal Cancer Updates From 2024 Summer Conferences

Debbie's Dream Foundation

S. Klempner

ESMO 2024 Insights: EPOC2001 Study - Lenvatinib + Pembro + FLOT in N…

2024 ESMO Annual Meeting Insights Hub

A. Kawazoe

ASCO® 2024 Summary: "Latest Practice-Changing Data in Gastroesophage…

COR2ED The Heart of Medical Education

E. Smyth, S. Klempner, J. Seligmann, D. Modest

GI Cancers: Hot Topics in 2024

Yale Cancer Center

J. Lacy

Controversies in the Predictive Value of PD-L1 for Anti-PD-1 Benefit…

Elizabeth Smyth

R. Sundar

MRD in GI Malignancies: Current Clinical Utility of ctDNA

Horizon CME

A. Scott

1L Therapy for Stage 4 Gastroesophageal Cancers: The Role of Biomark…

Hope for Stomach Cancer

D. Catenacci

ASCO® 2024 Summary: "Latest Practice-Changing Data in Breast Cancer,…

COR2ED The Heart of Medical Education

M. Socinski, P. R. Galle, S. Dawood, E. Smyth, S. Klempner

UChicago Medicine Best of ASCO® 2024: Upper GI & Pancreatic Cancers

UChicago Medicine Annual Practice Updates in Hematology and Oncology

M. Amin

ASCO® GI 2024 Panel Discussion: "SKYSCRAPER-08 Clinical Implications…

Insights from 2024 ASCO® GI Annual Meeting

Y. Janjigian, S. Cytryn, S. Klempner

ASCO® 2024 Insights: "3Yr Follow-Up of RATIONALE-306 - Tislelizumab …

2024 ASCO® Annual Meeting Insights Hub

H. Yoon